4.7 Article

Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes

期刊

AMERICAN JOURNAL OF CLINICAL NUTRITION
卷 92, 期 6, 页码 1350-1358

出版社

AMER SOC CLINICAL NUTRITION
DOI: 10.3945/ajcn.110.003970

关键词

-

资金

  1. NHLBI
  2. NIDDK [R01 HL085710, DK064360, DK71507 04]
  3. CHS [N01 HC 35129, N01 HC 45133, N01 HC 75150, N01 HC 85079, 85086, N01 HC 15103, N01 HC 55222, U01 HL080295]
  4. Office of Dietary Supplements
  5. National Institute of Neurological Disorders and Stroke of the National Institutes of Health
  6. Searle Scholar Award

向作者/读者索取更多资源

Background Animal experiments suggest that circulating palmitoleic acid (cis 16 1n-7) from adipocyte de novo fatty acid synthesis may directly regulate insulin resistance and metabolic dysregulation Objective We investigated the independent determinants of circulating palmitoleate in free living humans and whether palmitoleate is related to lower metabolic risk and the incidence of diabetes Design In a prospective cohort of 3630 US men and women in the Cardiovascular Health Study plasma phospholipid fatty acids anthropometric variables blood lipids inflammatory markers and glucose and insulin concentrations were measured between 1992 and 2006 by using standardized methods Independent determinants of plasma phospholipid palmitoleate and relations of palmitoleate with metabolic risk factors were investigated by using multivariable adjusted linear regression Relations with incident diabetes (296 incident cases) were investigated by using Cox proportional hazards Results The mean (+/- SD) palmitoleate value was 0 49 +/- 0 20% (range 0 11-2 55%) of total fatty acids Greater body mass index carbohydrate intake protein intake and alcohol use were each in dependent lifestyle correlates of higher palmitoleate concentrations In multivariable analyses that adjusted for these factors and other potential confounders higher palmitoleate concentrations were in dependently associated with lower LDL cholesterol (P < 0 001) higher HDL cholesterol (P < 0 001) lower total HDL cholesterol ratio (P = 0 04) and lower fibrinogen (P < 0 001) However palmitoleate was also associated with higher triglycerides (P < 0 001) and (in men only) with greater insulin resistance (P < 0 001) Palmitoleate was not significantly associated with incident diabetes Conclusions Adiposity (energy imbalance) carbohydrate consumption and alcohol use-even within typical ranges-are associated with higher circulating palmitoleate concentrations Circulating palmitoleate is robustly associated with multiple metabolic risk factors but in mixed directions perhaps related to diver gent lifestyle determinants or endogenous sources (liver adipose tissue) of fatty acid synthesis An, J Clin Nutr 2010 92 1350-8

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据